With Semaglutide, postmenopausal women can achieve significant weight loss, improve insulin sensitivity, and lower the risk ...

Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce ...

A new drug, called orforglipron, can help people with diabetes manage their A1C and weight, according to topline results from ...

Tirzepatide is the active ingredient in Zepbound, approved by the Food and Drug Administration (FDA) specifically for weight loss. Semaglutide was initially approved under the brand name Ozempic ...

Semaglutide is the active ingredient in Novo Nordisk A/S’ NVO Ozempic and Wegovy, which are available for diabetes and weight loss. In an ongoing study in healthy rats, a single administration ...

Scientists are trying to tackle Alzheimer's from all angles, and a new study adds to the growing evidence that semaglutide, a widely used diabetes and weight loss drug, could also be beneficial in ...

NanoPortal™ technology successfully delivers semaglutide ... treatment resulted in nearly 20% placebo-adjusted weight loss from a single administration with expected once or twice-yearly ...

The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

Hims & Hers (HIMS) stock slid Wednesday, a day after the company announced new weight-loss drug offerings — an update that left investors unimpressed.

which are available for diabetes and weight loss. In an ongoing study in healthy rats, a single administration of the semaglutide implant NPM-139 resulted in body weights nearly 20% lower than a ...